Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00350051 · ClinicalTrials.gov registry record · Phase 2

ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-independent Prostate Cancer

A Phase 2 study of Prostate Cancer, sponsored by Bayer.

Completed
Registry status
Phase 2
Development phase
53
Enrollment target
17
Study locations

NCT00350051 is a Phase 2 study of Prostate Cancer that has completed, run by Bayer. The registered enrollment target is 53 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (91% lower). The trial reports 17 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00350051, a Phase 2 study of Prostate Cancer, has completed, sponsored by Bayer.

COMPLETED
Registry status
Phase 2
Development phase
53 participants
Enrollment target
17
Study locations

Study Summary

The purpose of this study is to evaluate whether treatment with a new drug called ZK-Epothilone (ZK-Epo) given with prednisone in patients with androgen-independent prostate cancer, who have not had previous chemotherapy, is safe and helps to decrease PSA (Prostate-specific antigen) levels.

Conditions Studied

Prostate Cancer

Interventions

  • DRUG Sagopilone (ZK 219477) + prednisone

Study Locations (17)

Other

  • - Buenos Aires
  • - Buenos Aires
  • - Buenos Aires
  • - Córdoba

California

  • - Fountain Valley

Florida

  • - Sarasota

Maryland

  • - Baltimore

Michigan

  • - Ann Arbor

Montana

  • - Billings

Nebraska

  • - Omaha

New York

  • - The Bronx

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2006-08-01
Est. Completion 2009-12-21
Phase Phase 2

Sponsor

Bayer

591 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00350051

The ClinicalTrials.gov registry entry for NCT00350051 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (91% lower). The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Sagopilone (ZK 219477) + prednisone is the first listed.

NCT00350051 reports 17 study locations spanning 14 distinct geographic areas - top geographies include Other, California, Florida.

Frequently Asked Questions

What is clinical trial NCT00350051 about?

NCT00350051 is a clinical study titled "ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-independent Prostate Cancer". The purpose of this study is to evaluate whether treatment with a new drug called ZK-Epothilone (ZK-Epo) given with prednisone in patients with androgen-independent prostate cancer, who have not had previous chemotherapy, is safe and helps to decrease PSA (Prostate-specific antigen) levels.

What is the current status of trial NCT00350051?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 53 participants. The study started on 2006-08-01. Estimated completion is 2009-12-21.

What conditions does trial NCT00350051 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT00350051?

The interventions under investigation include: Sagopilone (ZK 219477) + prednisone (DRUG).

Who is sponsoring clinical trial NCT00350051?

This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00350051 being conducted?

This trial has 17 study locations across California, Florida, Maryland, Michigan, Montana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.